Stendra: A Fast-Acting Solution for Erectile Dysfunction in American Men
Reading Time: 2 minutes Introduction to Stendra Stendra, generically known as avanafil, represents a significant advancement in the treatment of erectile dysfunction (ED), a condition affecting millions of American men. Introduced to the market as a fast-acting phosphodiesterase type 5 (PDE5) inhibitor, Stendra has carved a niche for itself by offering a rapid onset of action and a favorable side effect profile compared to its predecessors. The Discovery of Avanafil The journey of avanafil began in the laboratories of Mitsubishi Tanabe Pharma Corporation in Japan. Researchers were on a quest to develop a PDE5 inhibitor that could provide a quicker onset of action and...


